DESIGN. OPTIMIZE. DEVELOP. Trademark

Trademark Overview


On Thursday, May 19, 2011, a trademark application was filed for DESIGN. OPTIMIZE. DEVELOP. with the United States Patent and Trademark Office. The USPTO has given the DESIGN. OPTIMIZE. DEVELOP. trademark a serial number of 85324623. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 31, 2012. This trademark is owned by BioCryst Pharmaceuticals, Inc.. The DESIGN. OPTIMIZE. DEVELOP. trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and drug development; medical and scientific research, namely conducting clinical trials; development of pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological and autoimmune diseases and disorders; development of pharmaceuticals for the treatment of influenza, hepatitis, AIDS, SARS, and West Nile virus; development of pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphoma
design. optimize. develop.

General Information


Serial Number85324623
Word MarkDESIGN. OPTIMIZE. DEVELOP.
Filing DateThursday, May 19, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 31, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 4, 2011

Trademark Statements


Goods and ServicesPharmaceutical research and drug development; medical and scientific research, namely conducting clinical trials; development of pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological and autoimmune diseases and disorders; development of pharmaceuticals for the treatment of influenza, hepatitis, AIDS, SARS, and West Nile virus; development of pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphoma

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 23, 2011
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBioCryst Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Party NameBioCryst Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Trademark Events


Event DateEvent Description
Monday, December 31, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 31, 2012ABANDONMENT - NO USE STATEMENT FILED
Friday, May 25, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 23, 2012EXTENSION 1 GRANTED
Wednesday, May 23, 2012EXTENSION 1 FILED
Wednesday, May 23, 2012TEAS EXTENSION RECEIVED
Tuesday, November 29, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 4, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 4, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 4, 2011PUBLISHED FOR OPPOSITION
Thursday, August 18, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 18, 2011ASSIGNED TO EXAMINER
Monday, May 23, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 23, 2011NEW APPLICATION ENTERED IN TRAM